Outcomes of younger patients with mantle-cell lymphoma experiencing late relapse (>24 months): the LATE-POD study. Malinverni C, Bernardelli A, Glimelius I, Mirandola M, et al. Blood 2024 May 16:blood.2023023525. doi: 10.1182/blood.2023023525.

Read + Share

Amedeo Smart

Independent Medical Education

Malinverni C, Bernardelli A, Glimelius I, Mirandola M, et al. Outcomes of younger patients with mantle-cell lymphoma experiencing late relapse (>24 months): the LATE-POD study. Blood 2024 May 16:blood.2023023525. doi: 10.1182/blood.2023023525.
PMID: 38754055